Seelos Therapeutics has recently shared promising findings from their latest preclinical study involving SLS-005, a potential treatment for aggressive Alzheimer’s disease. The study ut… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Spasticity pipeline constitutes 20+ key companies continuously working towards developing 20+ Spasticit… Read More
Central Nervous System Therapeutic Market Growth & Trends
The global central nervous system therapeutic market size is expected to reach USD 205.0 billion by 2028, according to a… Read More
Delveinsight Business Research LLP
The Multiple Sclerosis Market size in the seven major markets was found to be USD 22,381 million in 2020, which is expected to grow by 2032. As per De… Read More
Encinitas, California--(Newsfile Corp. - August 23, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it has been granted U.S. (Patent # 11,730,71… Read More
In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More
Global Pharmaceutical leaders GSK and Sanofi competing for market share in vaccines, general healthcare with investments in R&D and new collaborations.
Storyline
Sanofi, a global p… Read More
Best 10 Global Pharmaceutical Brands
Md. Joynal Abdin*
Business Consultant & Digital Marketer
Co-Founder & CEO of Bangladesh Trade Center
The international trade of pharmaceutical p… Read More
Advancements in neuroscience research and technology are paving the way for groundbreaking developments in the field of neurology. At the 2022 Precision Neuroscience Summit, scientists and i… Read More
DelveInsight Business Research LLP
DelveInsight’s “Optic Neuritis Disorder Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth unders… Read More
Delveinsight Business Research LLP
The Multiple Sclerosis (MS) market dynamics are anticipated to change in the coming years owing to the expected launch of emerging therapies such as N… Read More
The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK, and Bristol-Myers Squibb
The team… Read More
Rare Neurodegenerative Disease Treatment Market: Overview
According to the latest research report on the global rare neurodegenerative disease treatment market for the historical year&nbs… Read More
By Ludwig Burger
BASEL (Reuters) – Roche warned of a decline in 2023 earnings, as revenue growth from new drugs, including its haemophilia treatment and multiple sclerosis drug, would… Read More
Nerve repair and regeneration market was valued at USD 8.32 billion by 2023, growing with 9.9% CAGR during the forecast period, 2023-2033.Nerve repair and regeneration is the… Read More
TipRanks
Billionaire David Shaw Pours Money Into 3 “Strong Buy” Stocks
Are the tides turning on Wall Street? Stocks fell in the past three trading sessions, as investors abandon… Read More
The conventional practices are being augmented through robotic, AI-driven systems, thereby taking the past as well as present to the future. This would, in true sense, let clinicians carve c… Read More
Autoimmune Disease TreatmentThe immune system attacks its own body tissue as a result of an autoimmune disease. More than 80 different autoimmune disorders exist, although lupus, multiple sc… Read More
After sliding to its lowest level since 2013, Biogen Inc. (NASDAQ:BIIB) was almost forgotten by growth investors. That changed dramatically late last month when the… biotechs pipe… Read More
Bill Radvak, Co-founder and Executive Chairman of the Board, appointed interim Chief Executive Officer Dr. Adam Rogers, member of the Board of Directors, appointed interim President Paul Bre… Read More
Akili Interactive is the latest company to go public via SPAC deal (Boston Business Journal):
Boston’s Akili Interactive Labs Inc. is the latest Massachusetts-based company to go publi… Read More